Latest news with #Bernstein
Business Insider
an hour ago
- Automotive
- Business Insider
Bernstein Remains a Hold on Stellantis (STLA)
Bernstein analyst Stephen Reitman maintained a Hold rating on Stellantis (STLA – Research Report) today and set a price target of $11.70. Confident Investing Starts Here: Reitman covers the Consumer Cyclical sector, focusing on stocks such as Stellantis, Bayerische Motoren Werke Aktiengesellschaft, and Mercedes-Benz Group. According to TipRanks, Reitman has an average return of 7.5% and a 50.00% success rate on recommended stocks. In addition to Bernstein, Stellantis also received a Hold from RBC Capital's Tom Narayan in a report issued on May 28. However, on May 19, Wells Fargo maintained a Sell rating on Stellantis (NYSE: STLA).
Business Insider
an hour ago
- Business
- Business Insider
Daiichi Sankyo Company (DSKYF) Receives a Buy from Bernstein
Bernstein analyst Miki Sogi maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target of Yen6,400.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Sogi is an analyst with an average return of -1.9% and a 45.45% success rate. Sogi covers the Healthcare sector, focusing on stocks such as Daiichi Sankyo Company, Astellas Pharma, and Chugai Pharmaceutical Co. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Daiichi Sankyo Company with a $40.43 average price target. The company has a one-year high of $44.64 and a one-year low of $20.15. Currently, Daiichi Sankyo Company has an average volume of 76.67K.
Time of India
3 hours ago
- Business
- Time of India
Bernstein raises Reliance Industries target price to ₹1,640, citing 3-year low valuation
Seeing a 3-year low valuation in Reliance Industries Ltd (RIL) shares, global brokerage firm Bernstein has raised its target price on the stock to ₹1,640, implying a potential upside of 15.4% from the stock's previous close, while maintaining an 'outperform' rating on the should also be noted that Bernstein's target price on the stock is even higher than the latter's 52-week high of ₹1,608.95 on the BSE. The revision in the target price comes on the back of the brokerage firm citing strengthening growth momentum, an improving earnings outlook, coupled with supportive valuations. Bernstein noted that Reliance is nearing the end of a major store rationalization cycle in its retail segment, which involved the closure of over 2,100 underperforming stores in FY2025. With that process largely complete, the brokerage expects a shift from aggressive expansion to steady revenue and EBITDA growth. Bernstein has projected a compound annual growth rate (CAGR) of 16% and 20% for revenue and EBITDA, respectively, over FY2025–27 in the retail segment. On the telecom front, continued tariff repair is expected to support earnings growth. Bernstein forecasts 13% CAGR in revenue for Jio over the next two years, supported by rising ARPU (average revenue per user) and further rollout of Jio AirFiber. The brokerage anticipates subscriber additions and growing broadband adoption to drive further gains, with Jio expected to reach a subscriber base of 500 million and a market share of 48% by FY27. In the new energy segment, Reliance's ventures in solar, battery, electrolyzers, and fuel cells are gaining traction. The company has commenced operations with a 1GW production line and aims to reach 10GW capacity by 2026. Bernstein highlighted this segment as a long-term growth pillar, supported by the company's planned investment of US$2 trillion through 2050.' Also read: No betting on market till July; AI companies to take a couple of years to take off in India: Ajay Bagga Bernstein also underlined Reliance's disciplined approach to capital allocation, with capital expenditure moderating and the net debt to EBITDA ratio remaining flat in FY2025. At a current 10.1x one-year forward EV/EBITDA multiple, the stock trades at a 15% discount to its three-year average valuation, making the risk-reward ratio attractive, the brokerage said. Around 12:40 pm today, the shares of Reliance Industries were trading 0.89% lower at ₹1,408.10 on the BSE.
Business Insider
5 hours ago
- Business
- Business Insider
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV) and Gilead Sciences (GILD)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie (ABBV – Research Report) and Gilead Sciences (GILD – Research Report). Confident Investing Starts Here: AbbVie (ABBV) In a report issued on May 31, Courtney Breen from Bernstein maintained a Hold rating on AbbVie. The company's shares closed last Friday at $186.11. According to Breen is a 2-star analyst with an average return of -0.1% and a 27.8% success rate. Breen covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and Gilead Sciences. AbbVie has an analyst consensus of Moderate Buy, with a price target consensus of $212.13, implying a 14.7% upside from current levels. In a report issued on May 30, Berenberg Bank also maintained a Hold rating on the stock with a $170.00 price target. Gilead Sciences (GILD) In a report released yesterday, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences, with a price target of $125.00. The company's shares closed last Friday at $110.08. According to Biegler is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -14.6% and a 28.7% success rate. Biegler covers the Healthcare sector, focusing on stocks such as Acrivon Therapeutics, Inc., Day One Biopharmaceuticals, and Zentalis Pharmaceuticals. Currently, the analyst consensus on Gilead Sciences is a Strong Buy with an average price target of $120.47, implying a 7.9% upside from current levels. In a report issued on May 21, Jefferies also maintained a Buy rating on the stock with a $130.00 price target.
Time of India
5 hours ago
- Business
- Time of India
Bernstein raises Reliance Industries target price to ₹1,640, citing 3-year low valuation
Seeing a 3-year low valuation in Reliance Industries Ltd (RIL) shares, global brokerage firm Bernstein has raised its target price on the stock to ₹1,640, implying a potential upside of 15.4% from the stock's previous close, while maintaining an 'outperform' rating on the same. It should also be noted that Bernstein's target price on the stock is even higher than the latter's 52-week high of ₹1,608.95 on the BSE. The revision in the target price comes on the back of the brokerage firm citing strengthening growth momentum, an improving earnings outlook, coupled with supportive valuations. Bernstein noted that Reliance is nearing the end of a major store rationalization cycle in its retail segment, which involved the closure of over 2,100 underperforming stores in FY2025. With that process largely complete, the brokerage expects a shift from aggressive expansion to steady revenue and EBITDA growth. Bernstein has projected a compound annual growth rate (CAGR) of 16% and 20% for revenue and EBITDA, respectively, over FY2025–27 in the retail segment. On the telecom front, continued tariff repair is expected to support earnings growth. Bernstein forecasts 13% CAGR in revenue for Jio over the next two years, supported by rising ARPU (average revenue per user) and further rollout of Jio AirFiber. The brokerage anticipates subscriber additions and growing broadband adoption to drive further gains, with Jio expected to reach a subscriber base of 500 million and a market share of 48% by FY27. In the new energy segment, Reliance's ventures in solar, battery, electrolyzers, and fuel cells are gaining traction. The company has commenced operations with a 1GW production line and aims to reach 10GW capacity by 2026. Bernstein highlighted this segment as a long-term growth pillar, supported by the company's planned investment of US$2 trillion through 2050.' Bernstein also underlined Reliance's disciplined approach to capital allocation, with capital expenditure moderating and the net debt to EBITDA ratio remaining flat in FY2025. At a current 10.1x one-year forward EV/EBITDA multiple, the stock trades at a 15% discount to its three-year average valuation, making the risk-reward ratio attractive, the brokerage said. Around 12:40 pm today, the shares of Reliance Industries were trading 0.89% lower at ₹1,408.10 on the BSE.
